@article{Proskurina_2021,<br/><span class="tab"></span> title={Recommendations on the Clinical Trial Programme for Diabetes Medicines},<br/><span class="tab"></span> volume={11},<br/><span class="tab"></span> ISSN={1991-2919},<br/><span class="tab"></span> url={http://dx.doi.org/10.30895/1991-2919-2021-11-2-94-103},<br/><span class="tab"></span> DOI={10.30895/1991-2919-2021-11-2-94-103},<br/><span class="tab"></span> number={2},<br/><span class="tab"></span> journal={The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products},<br/><span class="tab"></span> publisher={SCEEMP},<br/><span class="tab"></span> author={Proskurina,<br/><span class="tab"></span> I. A. and Petraneva,<br/><span class="tab"></span> E. A. and Goryachev,<br/><span class="tab"></span> D. V.},<br/><span class="tab"></span> year={2021},<br/><span class="tab"></span> month=jul,<br/><span class="tab"></span> pages={94–103} }